6-K ·Filed Jul 27, 2026

SNN

SMITH & NEPHEW PLC
BULLISH
Impact 6/10
Horizonweeks Processed2mo ago SEC0001654954-26-006900
Notable filing: 6-K
Actionable Insight ▲ Bullish

Monitor for further activist filings, potential board nominations, or strategic announcements from Smith & Nephew. The stake increase suggests Cevian may escalate its campaign, which could drive a merger, divestiture, or operational turnaround. Traders should consider positioning for a re-rating catalyst over the next 3-6 months.

DirectionBullish
Confidencehigh
Horizonweeks
Latest settled — T+20d
SNN ▼ -4.82% at T+20d
LONG call ✗ call lost -4.82% · α vs SPY -8.12% · entry $31.12 → $29.62
Next anchor: T+60d in 18d
Latest observation: T+44 -8.98% FF3 residual α
Entry anchored
Jul 24, 03:59 PM ET
via exchange tick
T+1d
+4.63%
call +4.63% · α +4.39%
$32.56
settled 2mo ago
T+5d
+1.41%
call +1.41% · α +0.34%
$31.56
settled 2mo ago
T+20d
-4.82%
call -4.82% · α -8.12%
$29.62
settled 6w ago
T+60d
—
call — · α —
—
in 18d

Price Chart

Loading chart...

Executive Summary

Cevian Capital, a prominent activist investor, increased its stake in Smith & Nephew to 14.01% from 13.21%, representing a $1.8B+ position. The increase signals continued or heightened activist pressure, and the cross-filing context with the recent annual report amplifies the significance, suggesting potential strategic changes ahead.

Key Facts

  • Cevian Capital II GP Limited increased voting rights stake to 14.010786% from 13.206621% as of July 22, 2026.
  • Total voting rights held: 117,912,733 shares.
  • Cevian Capital II Master Fund L.P. holds 12.815710% and Cevian Capital II Co-Investment - Series P L.P. holds 1.195075%.
  • Cevian is a well-known activist investor, often pushing for operational improvements or strategic changes.

Financial Impact

14.01% stake in a $13.0B market cap company implies a position of approximately $1.82B.

share priceactivist engagement

Risk Factors

  • Activist campaigns can be disruptive and may not realize value if management resists effectively.
  • Historical performance shows prior long calls on SNN have delivered negative T+20 returns, cautioning against over-optimism.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
50% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-006900
Document: 0001654954-26-006900-index-headers.html0001654954-26-006900
Document: 0001654954-26-006900-index.html0001654954-26-006900
Document: 0001654954-26-006900.txt0001654954-26-006900
30 reports for SNN
Performance horizon
86% Hit rate 6 of 7 directional calls best @ T+20▲ +8.02%Jun 30, 2026
Filters
Rows
Reports for SNN — sortable, filterable
TypeNow
Sep 16, 2026
16d ago
6-K
NEUTRAL ★ 3/10
$27.80 $26.82▼ −3.53%▼ −6.09%$26.42 (−4.96%)
Sep 16, 2026
16d ago
6-K
NEUTRAL ★ 3/10
$27.80 $26.82▼ −3.53%▼ −6.09%$26.42 (−4.96%)
Sep 11, 2026
21d ago
6-K
NEUTRAL ★ 4/10
$27.50 $27.56▲ +0.22%▲ +0.44%$26.42 (−3.93%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 4/10
$27.62 $27.78▲ +0.58%▲ +1.08%$26.42 (−4.34%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 4/10
$27.62 $27.78▲ +0.58%▲ +1.08%$26.42 (−4.34%)
Sep 9, 2026
23d ago
6-K
NEUTRAL ★ 2/10
$27.80 $28.06▲ +0.94%▲ +1.27%$26.42 (−4.96%)
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 4/10
$27.87 $28.01▲ +0.50%▲ +1.62%$26.42 (−5.20%)
Sep 2, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.66 $27.62▼ −3.63%▼ −2.67%$26.42 (−7.82%)
Sep 2, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.66 $27.62▼ −3.63%▼ −2.67%$26.42 (−7.82%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.97 $27.80▼ −4.04%▼ −4.12%$26.42 (−8.80%)
Showing 10 of 30

US Market Status

Market Closed — Opens Mon (64h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access